BACH1 and breast cancer: Taken together, our data, for the first time, indicated that BACH1 acted as a direct target of miR-299, which was negatively regulated by miR-299 in BC cells, and we have also proved a new regulatory pathway of glycolysis in BC cells, namely SNHG5/miR-299/BACH1 axis.